Lozol Oral Tablet 1.25Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Lozol: Oral tablet (1.25mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_8464.JPG
Indapamide 1.25mg Tab
Actavis US
Pill Identification: 597  |  LOGO
Drug Image file DrugItem_6790.JPG
Indapamide 1.25mg Tab
Actavis US
Pill Identification: 597  |  LOGO
Drug Image file DrugItem_6791.JPG
Indapamide 1.25mg Tab
Mylan Pharmaceuticals Inc.
Pill Identification: 69  |  M
Drug Image file DrugItem_3963.JPG
Indapamide 1.25mg Tab
Prasco Laboratories
Pill Identification: 111  |  TL
Drug Image file DrugItem_153.JPG
Indapamide 1.25mg Tab
Teva Pharmaceuticals USA
Pill Identification: Z 4262  |  1.25
Drug Image file DrugItem_6949.JPG
Lozol 1.25mg Tab
Sanofi U.S. LLC
Pill Identification: R  |  7
Drug Image file DrugItem_7392.JPG
Indapamide 1.25mg Tab
Teva Pharmaceuticals USA
Pill Identification: Z 4262  |  1.25
Drug Image file DrugItem_6535.JPG
Indapamide 1.25mg Tab
Par Pharmaceuticals, an Endo Company
Pill Identification: I E 1.25  |  G
Drug Image file DrugItem_11782.JPG
Indapamide 1.25mg Tab
PD-Rx Pharmaceuticals, Inc.
Pill Identification: 69  |  M
Drug Image file DrugItem_21020.JPG
Indapamide 1.25mg Tab
AvKARE, Inc.
Pill Identification: 597  |  LOGO
Drug Image file DrugItem_26800.JPG
Indapamide 1.25mg Tab
Golden State Medical Supply, Inc.
Pill Identification: ANI 510 
Drug Image file DrugItem_26683.JPG
Indapamide 1.25mg Tab
ANI Pharmaceuticals, Inc.
Pill Identification: ANI 510 

What is this Medicine?

INDAPAMIDE (in DAP a mide) is a diuretic. It helps you make more urine and to lose salt and excess water from your body. This medicine is used to treat high blood pressure. It is also used to treat salt and water retention from heart failure.

In-Depth Information

Lozol 1.25mg Tablet

NDC: 000750700
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Edema, Heart Failure, Hypertension

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Avoid excessive heat (above 104 degrees F)
Lozol 1.25mg Tablet
Drug Image file DrugItem_6949.JPG
Sanofi U.S. LLC
Pill Identification: R  |  7
Shape: octagonal (8-sided)
Color: orange

Reported Side Effects for Lozol 1.25mg Tablet

Stomach Pain Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Inflamed Blood Vessels Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Vomiting Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Chest Pain Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Increased Blood Sugar Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Flushing Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Glycosuria Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Excessive Mucle Tone Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Impotence (erectile Dysfunction) Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Sexual Desire Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Rash With Pustules Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Hives Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Constipation Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Cough Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Depression Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Inflamed Stomach Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Low Chloride Levels Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Sodium Levels Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Balance Problems Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Sinus Infection Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Inability To Sleep Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Postural Low Blood Pressure Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Sore Throat Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Runny Nose Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Paresthesias Incidence:
>5.0%*
Severity: MILD
Onset: DELAYED
Tired Incidence:
>5.0%*
Severity: MILD
Onset: EARLY
Rhinitis Incidence:
>5.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
>5.0%*
Severity: MILD
Onset: EARLY
Nervousness Incidence:
>5.0%*
Severity: MILD
Onset: DELAYED
Distressed Incidence:
>5.0%*
Severity: MILD
Onset: EARLY
Infection Incidence:
>5.0%*
Severity: MILD
Onset: DELAYED
Feeling Sick Incidence:
>5.0%*
Severity: MILD
Onset: EARLY
Irritability Incidence:
>5.0%*
Severity: MILD
Onset: DELAYED
Muscle Cramps Incidence:
>5.0%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
>5.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
>5.0%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
>5.0%*
Severity: MILD
Onset: DELAYED
Low Potassium Levels Incidence:
20.0-80.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
First Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Second Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Third Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Lozol

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5